Structural Formula (Acy01 0001 01)
Acyclovir Tablet
Product Images NDC 71205-053
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Acyclovir (NDC 71205-053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Acy01 0001 02)
Figure (Acy01 0001 03)
Figure (Acy01 0001 04)
Figure (Acy01 0001 05)
71205-56-30 (Acy01 0001 06)
This is a prescription drug called Acyclovir manufactured by Carlsbad Technology Inc. The tablets are white to off-white, unscored, oval-shaped, and engraved with "CTI" over "112". The medication comes in a bottle of 30 tablets, and each tablet contains 400 mg of Acyclovir USP. The drug is only available on prescription and should be kept out of the reach of children. The recommended storage temperature for the medication is between 20°C to 25°C. Also, it has various batch numbers and expiration dates specified in the text.*
71205-053-35 (Acy01 0001 07)
This is a description of a medication called Acyclovir, which comes in the form of 35 tablets, each containing 800mg of Acyclovir USP. The tablets are white to off-white, unscored, oval and engraved with "CTI" over "*113". The tablets are only available by prescription and should be stored at a temperature of 20°C-25°C (68°F-77°F) to maintain their quality. The medication is manufactured by Carlsbad Technology, Inc. and packaged by Proficient Rx LP. The lot number is 00000 and the expiration date is not readable. The National Drug Code (NDC) for this medication is 71205-053-35 and the barcode is GTIN: 0037120505352.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
